The PlexusDx test analyzes 14 appetite-control pathways and genes like GLP1R, GIPR, FTO, and MC4R to reveal your genetic predisposition to appetite dysregulation and GLP-1 response strength
This includes people with a family history of this cancer type, as well as individuals with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Individual health factors like genetic predisposition or existing conditions could also modify personal levels of acceptable intake
Because of that, stomach-related side effects tend to occur, particularly in the first few weeks
More point solutions create more noise and more confusion about where to go and who to trust
These help reduce appetite, improve metabolic response, and support steady fat loss when paired with the right plan